Latest Hudson Institute News | Page 5

Medical research to benefit from Morningside Ventures appointment
Australia’s largest group of inflammation researchers
Healthy workplaces program highlights Hudson Institute
COVID-19 treatment clinical trial underway
Major gift to Neonatal Paediatrics
Future leaders selected for industry mentoring
More clues discovered to male fertility and testicular cancer causes
Male fertility and testicular cancer linked to cell communication pathway
Umbilical cord blood could improve brain injury in babies
Kids thank their scientist superheroes amid pandemic
Securing Future Of Regenerative Medicine In Victoria
Personalised cancer treatments a step closer
Funding boost to develop lung treatment for premature babies
Backing Victoria’s next medical breakthroughs
Closing gap in tissue engineering
Creatine supplement safe for women
Combatting gene targeting challenges
Combatting challenges of new gene targeting medicines
Fetal surgery presentation by Ben Amberg wins Faculty 3MT
Infertility and testicular cancer linked to protein in pregnancy
Endometriosis provides answers for Bridget Hustwaite
Ingrid Dudink awarded Centennial Scholarship
Sepsis nearly took Dr Michael Gantier’s life. Now he studies it
Stem cell therapies receive MRFF funding
New findings impact disorders of sex development
Testosterone to prevent type 2 diabetes in men – promising, but no quick fix
Targeting childhood cancer
Boosting embryo implantation success
High blood pressure service increases referrals
Reproductive health three minute thesis winners announced
Pelvic organ prolapse treatment closer
Fetal growth restriction findings
NHMRC Investigator Grants success
$2.2 million awarded to tackle rare ovarian cancer
Researchers adapt and test snorkels to help stop COVID-19 spread
Male infertility expert joins Hudson Institute
Cell therapies trial planned for COVID-19
Monash researchers adapt and test snorkels to help stop COVID-19 spread
Male reproductive health problems could begin in womb
Weighing up home birth vs hospital in wake of coronavirus
US FDA approval sought for clinical trial for potential COVID-19 treatment
Our response to COVID-19
To our community
Cancer drug investigated as anti-inflammatory for lethal conditions including COVID-19
Keeping stomach cancer at bay
Simple blood test can improve ovarian cancer diagnosis
Gut bacteria and immune system-mapping out interactions
Unearthing a new form of toxic inflammation